Abstract
The present study was undertaken to detect Pneumocystis jirovecii infection among HIV-positive patients presenting with symptoms of lower respiratory tract infection and analyze the associated dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR) mutations. P. jirovecii infection was detected in 12.6 % cases. We did not find DHPS gene mutations at the commonest positions of codon 55 and 57; however, mutation at codon 171 was detected in two cases. No mutations in DHFR gene were detected. The results indicate low prevalence of DHPS and DHFR mutations in Indian P. jirovecii isolates, suggesting that the selective pressure of sulfa drugs on the local strains has probably not reached the levels found in developed nations.
References
Friaza V, Morilla R, Respaldiza N, et al. Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain. Postgrad Med. 2012;122:24–8.
Tyagi AK, Mirdha BR, Luthra K, et al. Study of dihydropteroate synthase (DHPS) gene mutations among isolates of Pneumocystis jirovecii. Indian J Med Res. 2008;128:734–9.
Alvarez-Martinez M, Moreno A, Miro JM, et al. Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality. Diagn Microbiol Infect Dis. 2008;62:34–43.
Valerio A, Tronconi E, Mazza F, et al. Genotyping of Pneumocystis jirovecii pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype. J Acquir Immune Defic Syndr. 2007;45:521–8.
Rabodonirina M, Vaillant L, Taffé P, et al. Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia. Emerg Infect Dis. 2013;19:21–8.
Taylor SM, Meshnick SR, Worodria W, et al. Low prevalence of Pneumocystis pneumonia (PCP) but high prevalence of Pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in Uganda. PLoS One. 2012;7:e9991. doi:10.1371/journal.pone.0049991.
Yoon C, Subramanian A, Chi A, et al. Dihydropteroate synthase mutations in Pneumocystis pneumonia: impact of applying different definitions of prophylaxis, mortality endpoints and mutant in a single cohort. Med Mycol. 2013;51:568–75.
Takahashi T, Endo T, Nakamura T, et al. Dihydrofolate reductase gene polymorphisms in Pneumocystis carinii f. sp. hominis in Japan. J Med Microbiol. 2002;51:510–5.
Costa MC, Esteves F, Antunes F, Matos O. Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal. J Antimicrob Chemother. 2006;58:1246–9.
Nahimana A, Rabodonirina M, Bille J, et al. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Antimicrob Agents Chemother. 2004;48:4301–5.
Esteves F, Gaspar J, Marques T, et al. Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data. Clin Microbiol Infect. 2010;16:878–84.
Queener SF, Cody V, Pace J, et al. Trimethoprim resistance of dihydrofolate reductase variants from clinical isolates of Pneumocystis jirovecii. Antimicrob Agents Chemother. 2013;574:990–8.
Tyagi AK, Mirdha BR, Luthra K, et al. Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia. J Infect Dev Ctries. 2010;4:761–6.
Wakefield AE, Pixley FJ, Banerji S, et al. Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol. 1990;43:69–76.
NACO. Antiretroviral Therapy guidelines for HIV infected adults and adolescents including post exposure prophylaxis. Ministry of Health and Family Welfare, Govt. of India, New Delhi; 2007. http://naco.gov.in/upload/Policies%20&%20Guidelines/7Guidelines%20for%20Prevention%20and%20Management%20of%20common%20opportunistic%20infections.pdf.
Vajpayee M, Kanswal S, Seth P, et al. Spectrum of opportunistic infections and profiles of CD4 cell counts among AIDS patients in Northern India. Infection. 2003;31:336–40.
Udwadia ZF, Doshi AV, Bhaduri AS. Pneumocystis carinii pneumonia in HIV infected patients from Mumbai. JAPI. 2005;53:437–40.
Chawla K, Martena S, Gurung B, et al. Role of PCR for diagnosing Pneumocystis jirovecii pneumonia in HIV-infected individuals in a tertiary care hospital in India. Indian J Pathol Microbiol. 2011;54:326–9.
Lowe DM, Rangaka MX, Gordon F, et al. Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression. PLoS One. 2013;8:e69969. doi:10.1371/journal.pone.0069969.
Fisk DT, Meshnick S, Kazanjian PH. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis. 2003;36:70–8.
Wissmann G, Alvarez-Martinez M, Meshnick S, et al. Absence of dihydropteroate synthase mutations in Pneumocystis jirovecii from Brazilian AIDS patients. J Eukaryot Microbiol. 2006;53:305–7.
Beser J, Dini L, Botero-Kleiven S, et al. Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii isolated from Swedish patients. Med Mycol. 2012;50:320–3.
Munoz C, Zuluaga A, Restrepo A, et al. Molecular diagnosis and detection of Pneumocystis jirovecii DHPS and DHFR genotypes in respiratory specimens from Colombian patients. Diagn Microbiol Infect Dis. 2012;72:204–13.
Robert-Gangneux F, Perrot M, Rouille A, et al. Absence of Pneumocystis dihydropteroate synthase mutants in Brittany, France. Diagn Microbiol Infect Dis. 2013;76:113–5.
Deng X, Zhuo L, Lan Y, et al. Mutational analysis of Pneumocystis jirovecii dihydropteroate synthase and dihydrofolate reductase genes in HIV-infected patients in China. J Clin Microbiol 2014; JCM.01848-14; published ahead of print 13 August 2014.
Hauser PM, Nahimana A, Taffe P, et al. Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. Clin Infect Dis. 2010;51:28–33.
Ma L, Borio L, Masur H, et al. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J Infect Dis. 1999;180:1969–78.
Riebold D, Fritzsche C, Lademann M, et al. Pneumocystis jiroveci dihydropteroate synthase gene mutations at codon 171 but not at codons 55 or 57 detected in germany. Clin Infect Dis. 2006;42:582–3.
Siripattanapipong S, Leelayoova S, Mungthin M, et al. Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-infected patients. Med Mycol. 2008;46:389–92.
Matos O, Esteves F. Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations. Parasite. 2010;17:219–32.
Acknowledgments
The authors thank the support of all staff for collection of samples at the Department of Chest TB, Sassoon General Hospital and the NARI-VIA Clinic.
Conflict of interest
None.
Ethical standard
The study protocol was approved by the institutional ethical review boards of the National AIDS Research Institute, Pune, India and BJ Medical College and Sassoon General Hospitals, Pune, India.
Author information
Authors and Affiliations
Corresponding author
Additional information
The GenBank accession numbers for the dihydropteroate synthase (DHPS) gene sequences of the two mutant Pneumocystis jirovecii isolates are JX101868 and JX101869.
Rights and permissions
About this article
Cite this article
Mane, A., Gujar, P., Chandra, J. et al. Pneumocystis jirovecii Infection and the Associated Dihydropteroate Synthase (DHPS) and Dihydrofolate Reductase (DHFR) Mutations in HIV-Positive Individuals from Pune, India. Mycopathologia 179, 141–145 (2015). https://doi.org/10.1007/s11046-014-9818-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-014-9818-5